# LipoCheck

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lipocheck

- Industry: Healthcare IT
- Headquarters: Leipzig, Germany
- Website: www.lipocheck.de/
- Total disclosed funding: $2.7M
- Latest round: Seed (Mar 24, 2025)
- Investors on record: 5

## About

LipoCheck GmbH is a digital health platform focused on providing innovative solutions for individuals suffering from lipedema, offering personalized medical reports and therapy recommendations through its mobile applications.Founded in 2022 in Leipzig, Germany, LipoCheck GmbH specializes in addressing lipedema through digital health solutions. The company has completed 1 deal, most recently raising EUR 2.5 million in Seed funding on March 13, 2025. The funding round was led by Technologiegründerfonds Sachsen, with participation from Gateway Ventures and OHA Osnabrück Healthcare Accelerator. The founder's background information is currently unavailable.LipoCheck is a pioneering digital health platform dedicated to addressing the needs of individuals suffering from lipedema, a chronic condition characterized by painful fat distribution. Its core product offerings include the LipoCheck app and the LipoAlly app. The LipoCheck app enables users to upload photos and complete a questionnaire, allowing healthcare professionals specializing in lipedema to generate medical reports and therapy recommendations within a few days. The LipoAlly app provides additional support resources throughout the patient’s journey, helping users manage their condition effectively. The company primarily serves women affected by lipedema across Europe, with a client base exceeding 15,000 patients. The services are readily accessible online, allowing users to engage with healthcare professionals and gather necessary information anytime and anywhere.LipoCheck's revenue model focuses on providing digital health solutions directly to consumers, emphasizing subscriptions for its core services. The company facilitates transactions through its app, where users can access medical evaluations and supportive resources related to lipedema treatment. While precise pricing structures for services are not disclosed, the company employs a subscription-based model that allows patients to receive ongoing support and resources tailored to their needs. Additionally, LipoCheck may engage in partnerships with healthcare providers to enhance its service offerings, thus broadening its revenue streams while maintaining a focus on direct consumer engagement. The holistic approach and specialized services associated with LipoCheck distinguish it within the digital health market, reinforcing its commitment to improving the quality of life for individuals managing lipedema.In March 2025, LipoCheck GmbH raised EUR 2.5 million in Seed funding led by new investor Technologiegründerfonds Sachsen, with participation from GIMIC Ventures, OHA Osnabrück Healthcare Accelerator, and Gateway Ventures. The company will use the funding to develop additional AI modules, establish strategic alliances with doctors and insurance firms, and increase the scope of its telehealth offerings. Future growth strategies include designing new products to enhance user experience and expanding into new markets across Europe, aiming to reach additional patients by late 2025.

## Funding rounds

- Seed, Mar 24, 2025, $2.7M — CFH Management, OHA Osnabrück Healthcare Accelerator, Gateway Ventures, CITO, GIMIC GmbH

## Investors

- CFH Management (https://capitalatlas.ai/funds/cfh-management) — Seed
- OHA Osnabrück Healthcare Accelerator — Seed
- Gateway Ventures (https://capitalatlas.ai/funds/gateway-ventures) — Seed
- CITO (https://capitalatlas.ai/funds/cito) — Seed
- GIMIC GmbH — Seed